Let me be very clear, this is a bad idea
The safety and the convenience of use (once-daily or twice-daily doses in combination with metformin) of the DPP-4 inhibitors have made them one of the most commonly used drug options, particularly in the early stages of the disease, in patients with renal failure, and in elderly subjects.39 Glucagon-like peptide-1 (GLP-1) receptor agonists These drugs bind to the GLP-1 receptors, inducing a decrease in glucagon secretion and an increase in insulin secretion, both in a glycemia dependent manner
Start Your Wellness Plan If youre considering a structured approach to metabolic health and recovery, our team can help guide you
Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Hennekens CH, et al
A 2026 review in Anais Brasileiros de Dermatologia confirmed these reactions are typically local, appear within 24 to 48 hours of injection, and resolve in 3 to 5 days without stopping treatment
